1.1 |
4.3 |
GO:0060032 |
notochord regression(GO:0060032) |
0.7 |
3.7 |
GO:0015671 |
oxygen transport(GO:0015671) |
0.7 |
4.6 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
0.6 |
3.7 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.6 |
7.8 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 |
1.4 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
0.4 |
1.3 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.4 |
2.9 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
0.4 |
1.9 |
GO:0007223 |
muscular septum morphogenesis(GO:0003150) Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.3 |
1.2 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.3 |
0.9 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
0.3 |
2.7 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.3 |
0.3 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 |
1.7 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 |
1.4 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.3 |
1.4 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
0.3 |
1.6 |
GO:0072553 |
terminal button organization(GO:0072553) |
0.3 |
1.0 |
GO:0019042 |
viral latency(GO:0019042) |
0.2 |
1.0 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 |
1.0 |
GO:0009414 |
response to water deprivation(GO:0009414) |
0.2 |
0.7 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
0.2 |
0.7 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
0.2 |
0.7 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
0.2 |
0.9 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
0.2 |
1.1 |
GO:0014831 |
gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.2 |
0.4 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
0.2 |
0.6 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 |
0.8 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
0.2 |
0.6 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
0.2 |
0.6 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 |
0.6 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
0.2 |
1.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
0.2 |
0.8 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
0.2 |
1.0 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.2 |
1.6 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 |
0.4 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 |
0.7 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
0.2 |
1.3 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
0.2 |
2.4 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.2 |
1.5 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 |
0.4 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 |
3.0 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
0.2 |
0.7 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
0.2 |
0.7 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
0.2 |
0.7 |
GO:0032275 |
luteinizing hormone secretion(GO:0032275) positive regulation of gonadotropin secretion(GO:0032278) |
0.2 |
1.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 |
0.3 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.2 |
0.7 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
0.2 |
0.5 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
0.2 |
0.5 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 |
3.2 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
0.2 |
0.5 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.2 |
0.5 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) |
0.2 |
0.6 |
GO:0061626 |
pharyngeal arch artery morphogenesis(GO:0061626) |
0.2 |
0.8 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.1 |
0.4 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
0.1 |
0.4 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
0.1 |
0.6 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
0.1 |
0.6 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
0.1 |
0.6 |
GO:0007412 |
axon target recognition(GO:0007412) |
0.1 |
0.3 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
0.1 |
0.6 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
0.1 |
0.4 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
0.1 |
0.7 |
GO:0016266 |
O-glycan processing(GO:0016266) |
0.1 |
0.5 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
0.1 |
0.6 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
0.1 |
0.6 |
GO:0001842 |
neural fold formation(GO:0001842) |
0.1 |
0.9 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
0.1 |
0.2 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
0.1 |
0.6 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 |
0.9 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
0.1 |
0.8 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
0.1 |
1.8 |
GO:0006085 |
acetyl-CoA biosynthetic process(GO:0006085) |
0.1 |
0.8 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
0.1 |
0.4 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 |
0.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 |
0.4 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
0.1 |
1.0 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
0.1 |
0.7 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 |
2.1 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
0.1 |
0.4 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 |
0.3 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.1 |
0.5 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.1 |
0.3 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 |
1.2 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 |
0.3 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
0.1 |
0.9 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
0.1 |
1.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
0.1 |
0.3 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 |
0.3 |
GO:1905154 |
negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
0.1 |
0.8 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 |
1.0 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 |
0.2 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
0.1 |
0.3 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
0.1 |
0.8 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
0.1 |
0.7 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 |
1.4 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
0.1 |
0.4 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 |
0.4 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
0.1 |
0.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
0.1 |
0.3 |
GO:0000454 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.1 |
0.3 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
0.1 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
0.1 |
0.3 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 |
0.3 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
0.1 |
0.6 |
GO:0048069 |
eye pigmentation(GO:0048069) |
0.1 |
0.2 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
0.1 |
2.4 |
GO:0010842 |
retina layer formation(GO:0010842) |
0.1 |
1.2 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
0.1 |
0.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
0.1 |
0.9 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 |
0.9 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 |
0.2 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 |
0.6 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 |
0.5 |
GO:1903056 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
0.1 |
0.4 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 |
3.1 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
0.1 |
0.8 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
0.1 |
0.6 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 |
0.3 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
0.1 |
0.4 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
0.1 |
0.1 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.1 |
0.8 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
0.1 |
1.4 |
GO:0045116 |
protein neddylation(GO:0045116) |
0.1 |
0.7 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 |
0.5 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
0.1 |
0.2 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
0.1 |
0.5 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 |
0.4 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
0.1 |
0.2 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
0.1 |
0.2 |
GO:0033860 |
regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 |
0.3 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
0.1 |
0.6 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
0.1 |
0.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
0.1 |
0.3 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) Harderian gland development(GO:0070384) |
0.1 |
0.2 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
0.1 |
0.3 |
GO:0042938 |
dipeptide transport(GO:0042938) |
0.1 |
0.2 |
GO:0032512 |
regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 |
1.0 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
0.1 |
0.2 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 |
0.3 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 |
0.2 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
0.1 |
0.3 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 |
1.9 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
0.1 |
0.3 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
0.1 |
0.1 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.1 |
0.8 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 |
0.8 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.1 |
0.3 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
0.1 |
0.3 |
GO:0072309 |
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 |
0.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
0.1 |
1.1 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 |
0.4 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
0.1 |
0.9 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.1 |
0.8 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 |
0.7 |
GO:1902287 |
semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 |
0.8 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
0.1 |
0.2 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.1 |
0.4 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 |
0.3 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 |
0.2 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
0.1 |
0.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 |
0.8 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
0.1 |
0.4 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 |
0.1 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
0.1 |
0.6 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
0.1 |
0.4 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 |
1.0 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
0.1 |
1.3 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 |
0.3 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glycolytic process through glucose-1-phosphate(GO:0061622) glucose catabolic process to pyruvate(GO:0061718) |
0.1 |
0.7 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
0.1 |
0.3 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
0.1 |
0.5 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
0.1 |
0.2 |
GO:0045188 |
regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.1 |
0.2 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
0.1 |
0.5 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
0.1 |
0.3 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
0.0 |
0.3 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 |
0.1 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 |
0.4 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
0.0 |
0.3 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
0.0 |
0.1 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
0.0 |
0.2 |
GO:0030501 |
positive regulation of bone mineralization(GO:0030501) |
0.0 |
0.5 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
0.0 |
0.5 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
0.0 |
0.5 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
0.0 |
0.5 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 |
0.1 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 |
0.4 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 |
0.1 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.0 |
0.5 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 |
0.2 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 |
0.4 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
0.0 |
1.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
0.0 |
0.4 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
0.0 |
0.4 |
GO:0007379 |
segment specification(GO:0007379) |
0.0 |
1.4 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
0.0 |
0.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 |
0.4 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 |
1.0 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 |
0.2 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 |
0.2 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
0.0 |
0.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
0.0 |
0.3 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
0.0 |
0.1 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
0.0 |
0.2 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 |
1.9 |
GO:0060612 |
adipose tissue development(GO:0060612) |
0.0 |
0.2 |
GO:0046958 |
nonassociative learning(GO:0046958) |
0.0 |
0.5 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
0.0 |
1.3 |
GO:0009268 |
response to pH(GO:0009268) |
0.0 |
0.2 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 |
0.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
0.0 |
0.2 |
GO:0060690 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) |
0.0 |
0.1 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
0.0 |
1.0 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 |
1.0 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 |
0.2 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 |
0.4 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
0.0 |
0.2 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 |
0.1 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 |
0.8 |
GO:0006415 |
translational termination(GO:0006415) |
0.0 |
0.3 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 |
0.1 |
GO:0045950 |
female meiosis chromosome segregation(GO:0016321) negative regulation of mitotic recombination(GO:0045950) |
0.0 |
0.1 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 |
0.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
0.0 |
0.8 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
0.0 |
0.2 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
0.0 |
0.8 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
0.0 |
0.7 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 |
0.4 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
0.0 |
0.4 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 |
0.1 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
0.0 |
1.3 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
0.0 |
0.6 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 |
0.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
0.0 |
0.3 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
0.0 |
0.4 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
0.0 |
0.4 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 |
1.4 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 |
0.7 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.0 |
0.6 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
0.0 |
0.1 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.0 |
2.0 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 |
0.4 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
0.0 |
0.5 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 |
0.1 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 |
0.3 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) protein polyglutamylation(GO:0018095) |
0.0 |
0.7 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 |
0.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 |
0.8 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
0.0 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
0.0 |
0.2 |
GO:1902035 |
positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 |
0.5 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
0.0 |
0.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 |
0.1 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
0.0 |
0.4 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 |
0.3 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
0.0 |
1.7 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 |
0.1 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
0.0 |
1.0 |
GO:0031648 |
protein destabilization(GO:0031648) |
0.0 |
0.4 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
0.0 |
0.6 |
GO:0097178 |
ruffle assembly(GO:0097178) |
0.0 |
0.1 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.0 |
0.1 |
GO:0061724 |
lipophagy(GO:0061724) |
0.0 |
0.3 |
GO:0034242 |
negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.0 |
1.4 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
0.0 |
3.6 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
0.0 |
0.7 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 |
0.1 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
0.0 |
0.1 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
0.0 |
0.1 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
0.0 |
0.6 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
0.0 |
0.3 |
GO:1902855 |
regulation of nonmotile primary cilium assembly(GO:1902855) positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 |
0.3 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.0 |
0.1 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
0.0 |
0.0 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
0.0 |
0.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
0.0 |
0.3 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
0.0 |
0.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
0.0 |
0.3 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
0.0 |
0.1 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 |
0.3 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
0.0 |
0.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 |
0.1 |
GO:1902065 |
response to L-glutamate(GO:1902065) |
0.0 |
0.1 |
GO:1903887 |
common bile duct development(GO:0061009) motile primary cilium assembly(GO:1903887) |
0.0 |
0.2 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
0.0 |
0.1 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
0.0 |
0.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
0.0 |
0.2 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of adherens junction organization(GO:1903392) |
0.0 |
0.2 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
0.0 |
0.2 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.0 |
0.1 |
GO:0014047 |
glutamate secretion(GO:0014047) |
0.0 |
0.3 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
0.0 |
0.0 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
0.0 |
0.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 |
0.8 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
0.0 |
0.4 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
0.0 |
0.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
0.0 |
0.1 |
GO:0042438 |
melanin biosynthetic process(GO:0042438) |
0.0 |
0.3 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
0.0 |
0.1 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 |
0.1 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
0.0 |
0.2 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 |
0.2 |
GO:0001953 |
negative regulation of cell-matrix adhesion(GO:0001953) |
0.0 |
0.2 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
0.0 |
0.1 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.0 |
0.3 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
0.0 |
1.0 |
GO:0006342 |
chromatin silencing(GO:0006342) |
0.0 |
0.6 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 |
0.3 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 |
0.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 |
0.0 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
0.0 |
0.1 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 |
0.5 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
0.0 |
0.1 |
GO:0045579 |
positive regulation of B cell differentiation(GO:0045579) |
0.0 |
0.2 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
0.0 |
0.0 |
GO:0089700 |
positive regulation of T cell receptor signaling pathway(GO:0050862) protein kinase D signaling(GO:0089700) |
0.0 |
0.1 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 |
0.8 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
0.0 |
0.1 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.0 |
1.2 |
GO:0007416 |
synapse assembly(GO:0007416) |
0.0 |
0.1 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
0.0 |
0.1 |
GO:0060539 |
diaphragm development(GO:0060539) |
0.0 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
0.0 |
0.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
0.0 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
0.0 |
0.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
0.0 |
0.0 |
GO:0070344 |
fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
0.0 |
0.1 |
GO:0032094 |
response to food(GO:0032094) |
0.0 |
0.6 |
GO:0051782 |
negative regulation of cell division(GO:0051782) |
0.0 |
0.1 |
GO:0010922 |
positive regulation of phosphatase activity(GO:0010922) |
0.0 |
0.2 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
0.0 |
0.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
0.0 |
0.0 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 |
1.0 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
0.0 |
0.2 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 |
0.0 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.0 |
0.1 |
GO:1990403 |
embryonic brain development(GO:1990403) |
0.0 |
0.1 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.0 |
0.2 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.0 |
0.1 |
GO:0006108 |
malate metabolic process(GO:0006108) |